Nieuws

On 1 January 2013, the salary amounts set forth in the Law of 3 July 1978 on employment contracts are adapted in accordance with the indexation rules.

For notice periods, non-competition clauses, training clauses, arbitration clauses (art. 22bis, 65, 69, 82, 84, 85, 86/2 and 104 of the Law on employment contracts), the following amounts apply:

For probationary periods (art. 67 Law on employment contracts):

Ambos NBGO Lawyers organises in collaboration with Vandelanotte Corporate Finance and ING Bank a breakfast seminar on the sale and purchase of small and medium sized companies.

While you enjoy your breakfast, a lawyer, an accountant and a banker will guide you through the acquisition process, discuss certain important topics and will you be offered the opportunity to ask questions.

The leading Belgian biotech company, Thrombogenics, was honored with the Scrip Award for the "Best Licensing Agreement of 2012" worldwide in the biotech sector. Scrip Awards are the most prestigious international awards in the biotech sector.

Speakers: Carl Bevernage, Peter Van de Vijver

Language: NL, FR

Location and time: Ambos NBGO Brussels, 12.00 - 14.00 PM

Speakers: Christina Trappeniers, Stijn Verbeke, Filip De Schouwer

Languages: NL, FR

Location and time: Ambos NBGO Brussels, 8.00 – 10.00 pm
 

In its battle against social and tax fraud the legislator has modified the Act on Labour Relationships (1).

Three important modifications have been made:
 

Ambos NBGO advises and assists Idealabs with the set–up of an innovative fund structure that will operate as one of the first Belgian seed accelerator programs.

Ambos NBGO has assisted On Assignment, Inc., a US based provider of professionals in the life sciences, healthcare and technology sectors, with the preparation, negotiation and completion of its acquisition of the Valesta group, a privately owned provider of specialized staffing in the area of clinical research within Western Europe.

Ambos NBGO has assisted ThromboGenics (www.thrombogenics.com) with the preparation and organization of its auction procedure and with the subsequent preparation, negotiation and execution of the Commercialization/Licensing Agreement entered into with Alcon/Novartis for the product Ocriplasmin.

Ambos NBGO has assisted ThromboGenics with the preparation and organization of its auction procedure and with the subsequent preparation, negotiation and execution of the Commercialization/Licensing Agreement entered into with Alcon/Novartis for the product Ocriplasmin. This licensing agreement covers Europe and all other countries worldwide except the USA (www.alcon.com and www.novartis.com).